Ocular manifestations following COVID-19 vaccination

Mahendradas, Padmamalini; Mishra, Sai Bhakti; Sangoram, Rohini; Srinivasan, Sanjay; Kawali, Ankush; Patil, Aditya; Shetty, Rohit

doi:10.1186/s12348-023-00358-x

Journal of Ophthalmic Inflammation and Infection

Table 1 Table providing information about all patients, type of vaccines, ocular manifestations

From: Ocular manifestations following COVID-19 vaccination

Case no.	Age	Gender	Vaccine	Dose	Days	Eye	Anatomical diagnosis	Etiological diagnosis	Occurance	Presenting va	Final va
1	72	M	Covishield	1st	12	RE	PU	VIRAL-VZV	FIRST	1.0	0.6
2	42	M	Covishield	1st	45	BE	ES	VIRAL-HSV	FIRST	0.0	0.0
3	62	F	Covishield	1st	15	RE	AU	IDIO	FIRST	0.0	0.0
4	55	M	Covishield	2nd	26	LE	PU	IDIO	FIRST	0.0	0.0
5	32	M	Covishield	1st	16	RE	AU	HLA B27	RECURRENCE	0.0	0.0
6	38	M	Covaxin	2nd	2	BE	PANU	SARCOID	RECURRENCE	0.0	0.0
7	56	M	Covaxin	2nd	25	RE	AU	IDIO	FIRST	0.0	0.0
8	42	M	Covaxin	2nd	18	RE	AU	HLA B27	RECURRENCE	0.0	0.0
9	33	M	Covishield	1st	16	RE	PU	TB	FIRST	0.0	0.0
10	80	M	Covishield	2nd	12	BE	AU	IDIO	RECURRENCE	0.2	0.0
11	26	M	Covishield	1st	40	BE	PANU	VKH	FIRST	1.0	0.9
12	67	F	Covishield	2nd	35	LE	KU	VIRAL-VZV	RECURRENCE	0.6	0.4
13	26	F	Covishield	2nd	30	RE	AU	IDIO	FIRST	0.0	0.0
14	34	M	Covishield	1st	7	RE	AU	IDIO	FIRST	0.1	0.0
15	28	M	Covishield	2nd	13	RE	ES	IDIO	FIRST	0.0	0.0
16	58	F	Covishield	1st	10	BE	PANU	VKH	FIRST	0.5	0.2
17	36	M	Covishield	2nd	30	RE	KU	IDIO	FIRST	0.2	0.0
18	55	F	Covaxin	1st	15	RE	AU	VIRAL-VZV	RECURRENCE	1.2	0.7
19	67	F	Covishield	1st	5	RE	SU	VIRAL-VZV	RECURRENCE	2.0	3.0
20	77	M	Covishield	1st	30	LE	KU	VIRAL-UNCLASSIFIED	FIRST	0.7	0.3
21	25	M	Covishield	1st	5	BE	AU	IDIO	RECURRENCE	0.2	0.0
22	51	F	Covishield	1st	40	BE	PANU	SARCOID	RECURRENCE	0.0	0.0
23	37	M	Covishield	1st	16	BE	PANU	VKH	RECURRENCE	0.5	0.0
24	50	M	Covishield	2nd	10	RE	AU	IDIO	RECURRENCE	0.0	0.0
25	42	M	Covishield	1st	45	BE	ES	VIRAL-UNCLASSIFIED	FIRST	0.0	0.0
26	26	F	Covishield	2nd	15	BE	SKU	HLA B27	RECURRENCE	0.0	0.0
27	46	F	Covishield	1st	11	BE	ES	IDIO	RECURRENCE	0.3	0.0
28	55	F	Covishield	1st	45	RE	AU	HLA B27	RECURRENCE	0.0	0.0
29	55	M	Covishield	1st	30	LE	AU	VIRAL-VZV	FIRST	0.2	0.0
30	74	M	Covishield	2nd	20	BE	AU	VIRAL-VZV	RECURRENCE	0.5	0.0
31	42	M	Covishield	1st	45	BE	ES	VIRAL-UNCLASSIFIED	FIRST	0.0	0.0
32	37	M	Covaxin	2nd	2	BE	PANU	SARCOID	RECURRENCE	0.0	0.0
33	47	M	Covaxin	2nd	18	RE	AU	HLA B27	RECURRENCE	0.0	0.0
34	31	F	Covishield	2nd	50	RE	SU	TB	RECURRENCE	0.0	0.0
35	37	M	Covishield	1st	22	BE	PANU	SARCOID	RECURRENCE	0.0	0.0
36	46	M	Covishield	1st	30	LE	AU	HLA B27	RECURRENCE	0.0	0.0
37	53	F	Covishield	2nd	28	BE	IU	IDIO	RECURRENCE	0.2	0.0
38	60	M	Covishield	2nd	2	RE	KU	VIRAL-UNCLASSIFIED	RECURRENCE	3.0	0.0
39	39	F	Covishield	1st	15	BE	IU	VIRAL-UNCLASSIFIED	RECURRENCE	2.0	1.3
40	37	F	Covishield	1st	30	LE	AU	HLA B27	RECURRENCE	0.2	0.0
41	46	F	Covishield	2nd	55	RE	AU	HLA B27	RECURRENCE	0.2	0.0
42	32	M	Covishield	1st	16	RE	AU	HLA B27	RECURRENCE	0.2	0.0
43	19	M	Covishield	2nd	21	RE	AU	IDIO	RECURRENCE	0.0	0.0
44	52	M	Covishield	1st	13	LE	AU	HLA B27	RECURRENCE	0.2	0.0
45	47	M	Covishield	1st	7	BE	PU	IDIO	FIRST	0.8	0.2
46	56	F	Covishield	1st	45	LE	AU	VIRAL-VZV	FIRST	0.0	0.0
47	19	F	Covishield	2nd	25	BE	IU	IDIO	FIRST	0.0	0.0
48	35	F	Covishield	1st	55	LE	AU	HLA B27	RECURRENCE	0.2	0.0
49	49	F	Covishield	2nd	55	BE	PANU	IDIO	FIRST	3.0	3.0
50	34	F	Covishield	2nd	50	BE	IU	TB	FIRST	0.0	0.0
51	35	F	Covishield	2nd	45	RE	AU	IDIO	RECURRENCE	0.0	0.0
52	23	F	Covishield	2nd	50	BE	AU	IDIO	RECURRENCE	0.2	0.0
53	49	F	Covishield	2nd	30	BE	PU	IDIO	FIRST	0.2	0.0
54	28	M	Covishield	1st	50	LE	PANU	IDIO	FIRST	0.0	0.0
55	26	M	Covishield	1st	30	BE	SU	HLA B27	RECURRENCE	0.0	0.0
56	47	F	Covaxin	1st	15	LE	ES	IDIO	RECURRENCE	4.0	4.0
57	35	M	Covishield	1st	30	BE	PANU	SARCOID	RECURRENCE	0.0	0.0
58	55	M	Covishield	2nd	55	LE	AU	IDIO	RECURRENCE	0.2	0.0
59	52	F	Covishield	1st	40	LE	S	IDIO	RECURRENCE	0.0	0.0
60	48	F	Covaxin	1st	30	LE	PANU	SARCOID	RECURRENCE	0.2	0.0
61	40	F	Covishield	1st	30	BE	AU	VIRAL-HSV	FIRST	0.0	0.0
62	22	M	Covishield	2nd	10	BE	PANU	VKH	FIRST	0.3	0.2
63	19	F	Covishield	1st	15	BE	PU	IDIO	FIRST	1.2	0.3
64	29	M	Covishield	2nd	30	BE	PANU	IDIO	FIRST	0.0	0.0
65	25	F	Pfizer	Both	3	BE	PU	IDIO	RECURRENCE	0.0	0.0
66	52	F	Sputnik	1st	5	LE	PU	IDIO	FIRST	0.6	0.6
67	19	F	Covaxin	Both	22	BE	IU	JIA	RECURRENCE	0.6	0.2

Back to article page